Showing results (61-70 of 87) with videos related to
Sort By:
Pageof 9
Journal of Endocrinological Investigation|August 31, 2016
Influence of short-term selenium supplementation on the natural course of Hashimoto's thyroiditis: clinical results of a blinded placebo-controlled randomized prospective trialD Esposito, M Rotondi, G Accardo, et al.The American Journal of Physiology|August 4, 1998
Advancing age and insulin resistance: role of plasma tumor necrosis factor-alphaG Paolisso, M R Rizzo, G Mazziotti, et al.The Journal of Clinical Endocrinology and Metabolism|January 3, 2001
Parity as a thyroid size-determining factor in areas with moderate iodine deficiencyM Rotondi, G Amato, B Biondi, et al.Journal of Hypertension|April 1, 1999
Mean arterial blood pressure and serum levels of the molar ratio of insulin-like growth factor-1 to its binding protein-3 in healthy centenariansG Paolisso, M R Tagliamonte, M R Rizzo, et al.Thyroid : Official Journal of the American Thyroid Association|February 24, 2001
Postintervention serum TSH levels may be useful to differentiate patients who should undergo levothyroxine suppressive therapy after thyroid surgery for multinodular goiter in a region with moderate iodine deficiencyM Rotondi, G Amato, A Del Buono, et al.Journal of Endocrinological Investigation|August 2, 2002
Temporal relationship between the appearance of thyroid autoantibodies and development of destructive thyroiditis in patients undergoing treatment with two different type-1 interferons for HCV-related chronic hepatitis: a prospective studyG Mazziotti, F Sorvillo, G Stornaiuolo, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 16, 2001
Interferon-related thyroid autoimmunity and long-term clinical outcome of chronic hepatitis CF Morisco, G Mazziotti, M Rotondi, et al.Journal of Endocrinological Investigation|February 11, 1999
Occurrence of thyroid autoimmunity and dysfunction throughout a nine-month follow-up in patients undergoing interferon-beta therapy for multiple sclerosisM Rotondi, A Oliviero, P Profice, et al.Journal of Endocrinological Investigation|July 6, 2000
Long-term treatment with interferon-beta therapy for multiple sclerosis and occurrence of Graves' diseaseM Rotondi, G Mazziotti, B Biondi, et al.Journal of Endocrinological Investigation|March 17, 2018
The AMPK-activator AICAR in thyroid cancer: effects on CXCL8 secretion and on CXCL8-induced neoplastic cell migrationO Awwad, F Coperchini, P Pignatti, et al.Pageof 9